Channel Therapeutics Corporation
CHRO · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $513 | $96 | $55 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $40 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $815 | $0 | $0 | $0 |
| Total Curr. Assets | $1,369 | $96 | $55 | $0 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,369 | $96 | $55 | $0 |
| Liabilities | – | – | – | – |
| Payables | $1,897 | $4,621 | $2,994 | $2,580 |
| Short-Term Debt | $2,186 | $1,269 | $540 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $651 | $227 | $0 |
| Total Curr. Liab. | $4,083 | $6,541 | $3,762 | $2,580 |
| LT Debt | $0 | $0 | $0 | $1,100 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $1,100 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $4,083 | $6,541 | $3,762 | $3,680 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $0 | $0 | $0 |
| Retained Earnings | -$21,475 | -$13,520 | -$6,139 | -$3,680 |
| AOCI | $0 | $0 | -$10 | $0 |
| Other Equity | $18,760 | $7,075 | $2,442 | $0 |
| Total Equity | -$2,714 | -$6,445 | -$3,707 | -$3,680 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,369 | $96 | $55 | $0 |
| Net Debt | $1,673 | $1,172 | $485 | $1,100 |